Unknown PHASE4 INTERVENTIONAL 2-arm NCT01062139

Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy

A Randomized, Parallel, Double-blind, Multi-center, Comparative Study to Exploratively Evaluate the Efficacy and Safety of Cosalin® Monotherapy vs. Cosalin® and Xarlin® Combination Therapy in Patients With Allergic Rhinitis

Sponsor: HK inno.N Corporation

Conditions Perennial Allergic Rhinitis

Interventions Cosalin (Petasites hybridus CO2 extract) Xarlin (Levocetirizine)

Updated 7 times since 2017 Last updated: Feb 3, 2010 Started: Oct 31, 2009 Primary completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Perennial Allergic Rhinitis, this trial is ongoing. The trial is conducted by HK inno.N Corporation and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Aug 2020 — Jan 2021 [monthly]

Unknown Status PHASE4
Jun 2018 — Aug 2020 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Enrolling By Invitation → Unknown Status
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation PHASE4

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HK inno.N Corporation

Data source: HK inno.N Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.